SU

239.55

+3.37%↑

BAS

47.63

+5.42%↑

AM

320

+1.14%↑

REP

23.01

-2.04%↓

EXE.US

107.66

+0.36%↑

SU

239.55

+3.37%↑

BAS

47.63

+5.42%↑

AM

320

+1.14%↑

REP

23.01

-2.04%↓

EXE.US

107.66

+0.36%↑

SU

239.55

+3.37%↑

BAS

47.63

+5.42%↑

AM

320

+1.14%↑

REP

23.01

-2.04%↓

EXE.US

107.66

+0.36%↑

SU

239.55

+3.37%↑

BAS

47.63

+5.42%↑

AM

320

+1.14%↑

REP

23.01

-2.04%↓

EXE.US

107.66

+0.36%↑

SU

239.55

+3.37%↑

BAS

47.63

+5.42%↑

AM

320

+1.14%↑

REP

23.01

-2.04%↓

EXE.US

107.66

+0.36%↑

Search

Fugro NV

Atidarymo kaina

SektoriusEnergijos sektorius

10.2 8.22

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

9.425

Max

10.27

Pagrindiniai rodikliai

By Trading Economics

Pajamos

16M

-2.1M

Pardavimai

39M

943M

P/E

Sektoriaus vid.

9.307

66.822

Dividendų pajamingumas

1.4

Pelno marža

-0.223

Darbuotojai

9,062

EBITDA

67M

143M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+23.99% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.40%

3.56%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-124M

1.2B

Ankstesnė atidarymo kaina

1.98

Ankstesnė uždarymo kaina

10.2

Naujienos nuotaikos

By Acuity

50%

50%

57 / 137 reitingas Energy

Fugro NV Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Fugro NV Prognozė

Kainos tikslas

By TipRanks

23.99% į viršų

12 mėnesių prognozė

Vidutinis 12.25 EUR  23.99%

Aukščiausias 14.5 EUR

Žemiausias 10 EUR

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fugro NV kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

1

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

57 / 137 reitingas Energijos sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fugro NV

Fugro N.V., together with its subsidiaries, provides geo-data services for infrastructure, energy, and water industries in Europe, Africa, the Americas, the Asia Pacific, the Middle East, and India. It offers marine site characterization solutions, including geophysical survey, geotechnical investigation, and hydrography solutions, as well as geo-consulting solutions, such as ground modeling and geohazard risk assessment services. The company also provides marine asset integrity solutions comprising real-time monitoring and forecasting of weather, currents, and environmental conditions; subscription-based signals and positioning solutions; and construction support solutions, including survey systems and related activities, and inspection and monitoring solutions by acquiring and analyzing inspection data. In addition, it offers land site characterization solutions, such as geotechnical investigation, geophysical survey, monitoring, and testing solutions, as well as geo consulting solutions, such as geohazard risk assessment, foundation advice, water resource management, and flood control. Further, the company provides land asset integrity services, including geospatial data acquisition to map, inspect, and advise on rail, roads, and power lines. The company was incorporated in 1962 and is headquartered in Leidschendam, the Netherlands.
help-icon Live chat